This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-14 and is reviewed periodically as new material appears.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.
Type 1: Separate hard lumps, like nuts (difficult to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft (average stool) Type 5: Soft blobs with clear cut edges Type 6: Fluffy pieces with ragged edges, a mushy stool (diarrhoea) Type 7: Watery, no solid pieces, entirely liquid (diarrhoea) Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools as they are easy to defecate while not containing excess liquid, and 6 and 7 indicate diarrhoea. Some media describe type 4 as "ghost poop" or "perfect poop". In the initial study, in the population examined in this scale, the type 1 and 2 stools were more prevalent in females, while the type 5 and 6 stools were more prevalent in males; furthermore, 80% of subjects who reported rectal tenesmus (sensation of incomplete defecation) had type 7. These and other data have allowed the scale to be validated. The initial research did not include a pictorial chart with this being developed at a later point. The Bristol stool scale is also very sensitive to changes in intestinal transit time caused by medications, such as antidiarrhoeal loperamide, senna, or anthraquinone with laxative effect.
=== Geography of insect consumption === Insect species consumption varies by region due to differences in environment, ecosystems, and climate. The number of insect species consumed by country is highest in equatorial and sub-tropical regions, a reflection of greater insect abundance and biodiversity observed at lower latitudes and their year-round availability.
antibiotic resistance gene A gene that confers resistance to one or more specific antibiotic compounds. In molecular cloning, plasmid vectors are often designed to carry antibiotic resistance genes as selectable markers alongside other genes of interest, because it permits the artificial selection of successfully transformed cell populations when the cells are cultured in the presence of the antibiotic.
aa + ATP ⟶ aa-AMP + PPi aa-AMP + tRNA ⟶ aa-tRNA + AMP The amino acid is coupled to the penultimate nucleotide at the 3′-end of the tRNA (the A in the sequence CCA) via an ester bond (roll over in illustration).
Sources: en.wikipedia.org
Geckos, skinks, and some other lizards that are captured by the tail will shed part of the tail structure through a process called autotomy and thus be able to flee. The detached tail will continue to thrash, creating a deceptive sense of continued struggle and distracting the predator's attention from the fleeing prey animal. The detached tails of leopard geckos can wiggle for up to 20 minutes. The tail grows back in most species, but some, like crested geckos, lose their tails for the rest of their lives. In many species the tails are of a separate and dramatically more intense color than the rest of the body so as to encourage potential predators to strike for the tail first. In the shingleback skink and some species of geckos, the tail is short and broad and resembles the head, so that the predators may attack it rather than the more vulnerable front part. Reptiles that are capable of shedding their tails can partially regenerate them over a period of weeks. The new section will however contain cartilage rather than bone, and will never grow to the same length as the original tail. It is often also distinctly discolored compared to the rest of the body and may lack some of the external sculpting features seen in the original tail.
=== Other features === All versions of ColdFusion prior to 6.0 were written using Microsoft Visual C++. This meant that ColdFusion was largely limited to running on Microsoft Windows, although Allaire did successfully port ColdFusion to Sun Solaris starting with version 3.1. The Allaire company was sold to Macromedia, then Macromedia was sold to Adobe. Earlier versions were not as robust as the versions available from version 4.0 forward. With the release of ColdFusion MX 6.0, the engine had been re-written in Java and supported its own runtime environment, which was easily replaced through its configuration options with the runtime environment from Sun. Version 6.1 included the ability to code and debug Macromedia Flash.
Denis Henry Desty (21 October 1923 - 18 January 1994) was a British scientist and inventor, known primarily for his work in the fields of chromatography and combustion science. Desty twice won the Tswett Medal for Chromatography, in 1974 and 1978, and the Royal Society of Chemistry Award for Combustion Chemistry in 1982. Desty's contributions to the field of chromatography are remembered to this day by the presentation of an annual Desty Memorial Award for Innovation In Separation Science
Vigorous species and early-flowering hybrids do not require pruning, other than to occasionally remove tangled growth (as in C. armandii, C. montana, and C. tangutica) Large-flowered hybrids blooming in early summer on the previous season's growth can be pruned lightly in the dormant season for structure Late-flowering hybrids which bloom on the current season's growth can be pruned back to a pair of buds in the dormant season
After Majors was found guilty of assault and harassment amidst legal issues in December 2023, he was fired by Disney and Marvel Studios. At that time, Marvel was internally referring to The Kang Dynasty as Avengers 5; by early 2024, Marvel had decided to drop the Kang storyline and began searching for a new antagonist for the saga. At SDCC in July 2024, the fifth Avengers film was retitled Avengers: Doomsday (2026), with Robert Downey Jr.—who starred as the superhero Tony Stark / Iron Man in the Infinity Saga—cast as the Multiverse Saga's new antagonist Victor von Doom / Doctor Doom, for both Doomsday and Secret Wars.
Sources: en.wikipedia.org
In 80–85% of cases, the ALK detected in ALK-positive ALCL is a NPM1-ALK fusion protein. It is made by a fusion of NPM1 gene, which makes nucleophosmin 1, located on the long or "q" arm of chromosome 5 at position 35 (notated as 5q35) with the ALK gene located on the short or "p" arm of chromosome 2 at position 23 (notated as 2p23) to form a chimeric gene notated as (2;5)(p23;q35). In 13% of cases ALK fuses with the TPM3 gene or in <1% of cases for each of the following genes: TFG, ATIC, CLTC, TPM4, MSN, RNF213 (also termed ALO17), MYH9, or TRAF1. All of these fusion proteins are considered to act like NPMI-ALK in possessing high ALK activity that promotes the development and progression ALK-positive ALCL by activating the cell signaling pathways cited in the Introduction. 15% Of individuals with ALK-positive ALCL also have point mutations in the NOTCH1 gene. While most of these abnormalities are thought to be detrimental not all are. For example, DUSP22 gene rearrangements are associated with favorable outcomes in ALK-positive (as well as ALK-negative) ALCL.
The FMO method is implemented in GAMESS (US), ABINIT-MP, PAICS, and OpenFMO software packages, distributed free of charge. Fu, is a general open-source GUI that can generate input files for FMO. Another graphical user interface Facio developed by M. Suenaga has a very convenient specialised support of FMO (in addition to other features), with which an automatic fragmentation of molecular clusters, proteins, nucleotides, saccharides and any combination thereof (e.g., DNA and protein complexes in explicit solvent) can be done in a few minutes, and a manual fragmentation of solids and surfaces can be accomplished by clicking the bonds to be detached. Facio can also visualise results of FMO calculations, such as the pair interactions. (E – energy, G – gradient, H – Hessian; bold – can be used with PCM) GAMESS (US)
An initial lack of symmetry (for example, axial symmetry, in the case of axial oscillations) in the core power distribution (for example as a result of significant control rods movement) causes an imbalance in fission rates within the reactor core, and therefore, in the iodine-135 buildup and the xenon-135 absorption. In the high-flux region, xenon-135 burnout allows the flux to increase further, while in the low-flux region, the increase in xenon-135 causes a further reduction in flux. The iodine concentration increases where the flux is high and decreases where the flux is low. This shift in the xenon distribution is such as to increase (decrease) the multiplication properties of the region in which the flux has increased (decreased), thus enhancing the flux tilt. As soon as the iodine-135 levels build up sufficiently, decay to xenon reverses the initial situation. Flux decreases in this area, and the former low-flux region increases in power. Repetition of these patterns can lead to xenon oscillations moving about the core with periods on the order of about 24 hours. With little change in overall power level, these oscillations can significantly change the local power levels. This oscillation may go unnoticed and reach dangerous local flux levels if only the total power of the core is monitored. Therefore, most PWRs use tandem power range excore neutron detectors to monitor upper and lower halves of the core separately.
The Meeting of Teano between Garibaldi and King Victor Emmanuel II of Savoy took place on 26 October 1860, where he annexed Mezzogiorno. On 19 August 1860, Calabria was invaded from Sicily by Giuseppe Garibaldi and his Redshirts as part of the Expedition of the Thousand. Through King Francesco II of Naples had dispatched 16,000 soldiers to stop the Redshirts, who numbered about 3,500, after a token battle at Reggio Calabria won by the Redshirts, all resistance ceased and Garibaldi was welcomed as a liberator from the oppressive rule of the Bourbons wherever he went in Calabria. Calabria together with the rest of the Kingdom of Naples was incorporated in 1861 into the Kingdom of Italy. Garibaldi planned to complete the Risorgimento by invading Rome, still ruled by the pope protected by a French garrison, and began with semi-official encouragement to raise an army. Subsequently, King Victor Emmanuel II decided the possibility of war with France was too dangerous, and on 29 August 1862 Garibaldi's base in the Calabrian town of Aspromonte was attacked by the Regio Esercito. The Battle of Aspromonte ended with the Redshirts defeated with several being executed after surrendering while Garibaldi was badly wounded. With the plebiscite of 21 October 1860, Calabria and the other southern provinces became part of the Kingdom of Sardinia: consequently, elections were called to allow the newly annexed territories to select representation in Parliament. The election was held on 27 January 1861, and the new Parliament was inaugurated in Turin on February 18.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.